Physician profile
Andre Becker Uflacker
NPI 1396970323
$6,149.83
in general payments reported to CMS, 2019-2025
14 companies · $417 in 2025
The $417 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $186 · 2021: $369 · 2022: $4,554 · 2023: $189 · 2024: $68.45 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $3,516.07 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $894.31 | 2021-2025 | Endurant Iis, Kyphon Express II Kyphopak Tray, In.Pact Admiral |
| Penumbra, INC. | $398.13 | 2019-2025 | Indigo System |
| Medtronic Vascular, INC. | $276.74 | 2019-2020 | |
| Vasorum USA INC. | $266.90 | 2022 | |
| Davol INC. | $184.16 | 2025 | Arista, Phasix Mesh |
| Guerbet LLC | $171.04 | 2021 | |
| W. L. Gore & Associates, INC. | $144.93 | 2021 | |
| Bard Peripheral Vascular, INC. | $122.33 | 2022 | |
| Philips North America LLC | $80.00 | 2019 | |
| Cook Medical LLC | $60.20 | 2020-2022 | |
| Boston Scientific Corporation | $35.02 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Uflacker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.